A series of fascinating studies at Harvard University showed that many people respond positively to placebo pills — even when they are told that the pills don't have any active ingredients. Now researchers at UAB have partnered with a Harvard scientist to test these "open-label" placebos for the first time in cancer survivors.
Deadlines for abstracts are set for early fall and are open to graduate students, postdoctoral fellows, clinical fellows and residents.
Join a UAB team or create a team for the annual walk, which helps raise funds for research efforts.
Boni Elewski, M.D., and Wendy Cantrell, DNP, pursue research and therapies that bring new drugs to market and change patients’ lives.
This improvement in cognition persists despite a high-glycemic-index diet, a possible risk factor for Alzheimer’s.
Three-year grant establishes consortium to better organize and support collaborative research related to the loss of functional beta cell mass in type 1 diabetes.
Jianyi “Jay” Zhang, M.D., Ph.D., a national leader in myocardial bioenergetics, biomaterial and stem cells for cardiac repair, has been named the chair of the Department of Biomedical Engineering, a joint department in the Schools of Medicine and Engineering.
A UAB researcher suggests that autoimmune disease therapy may be an effective treatment for idiopathic pulmonary fibrosis.
Neuron-derived microRNAs obtained from blood samples may correlate with treatment response and could aid the search for new therapeutics.
HIV/AIDS is the leading cause of death worldwide for women ages 15-44 years, and UAB serves as a site for the latest study by the Microbicide Trials Network, which has previously studied this new approach with positive results in other female age groups.